InsidersTradesSigma
Discover the detailed record of transactions filed by SANTINI GINO, Director. Officer active across 4 companies, notably COLLEGIUM PHARMACEUTICAL, INC. Cumulatively, 7 disclosures have been logged. The latest transaction was disclosed on 25 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
7 of 7 declarations
Gino Santini is a board member at Collegium Pharmaceutical, Inc. and Intercept Pharmaceuticals, Inc. In this role, he contributes to the governance of the company, providing his expertise to guide strategic decisions.